Compare Medpace Holdings Inc (MEDP) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Vipshop Holdings Ltd - ADR — how do they compare? Medpace Holdings Inc trades at $530 (market cap $15.08B), while Vipshop Holdings Ltd - ADR trades at $14.63 (market cap $7.01B). The key difference: Medpace Holdings Inc is far larger — about 2.2× Vipshop Holdings Ltd - ADR's market cap, and Vipshop Holdings Ltd - ADR pays a 4.25% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | VIPS | |
|---|---|---|
Market Cap | $15.08B | $7.01B |
Sector | Technology | Consumer Cyclical |
52-Week High | $620.59 | $20.68 |
52-Week Low | $308.88 | $12.92 |
Enterprise Value | $14.55B | $3.60B |
Dividend Yield | — | 4.25% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% on the day, with a neutral technical signal and mixed oscillators. The stock shows strong profitability with a 17.19% net margin and 77.25% ROE, though valuations are elevated with a P/E of 33.22. Recent quarters have consistently beaten EPS estimates, but a class action lawsuit filed in June 2026 adds uncertainty. Revenue is projected to grow to $2.7B in 2026, while cash flow trends improve from negative to positive net cash flow.
The outlook is cautious due to high valuation and legal overhangs, but fundamental strength in earnings and backlog quality provides support. Analyst consensus is mixed with a $497 price target below current levels, indicating limited near-term upside. Key risks include lawsuit outcomes and competitive pressures in the CRO sector.
Vipshop Holdings (VIPS) trades at $14.69, up 1.31% with a bullish technical signal. The stock shows strong fundamentals with a low P/E of 6.66 and robust profitability metrics including 18.43% ROE. Recent Q1 2026 earnings met expectations with management focusing on outlet strategy expansion through REIT spinoffs to drive growth.
The outlook remains positive with 53.57% analyst buy ratings supporting valuation upside potential. Key risks include Chinese consumer spending volatility and competitive e-commerce pressures. Revenue stabilization and margin improvements in 2026 projections suggest recovery potential after recent declines.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Vipshop Holdings Ltd - ADR
Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.
Read more on VIPS →
